By joining Bio-Techne, you’ll join a company with a powerful and positive purpose of enabling cutting-edge research in Life Sciences and Clinical Diagnostics. Bio-Techne, and all of its brands, provides tools for researchers to further treat and prevent disease worldwide.
Pay Range:
$153,300.00 - $251,850.00About the Role:The Director, Portfolio Management within the Advanced Cell Systems (ACS) Business Unit will drive long-term value creation across RUO Proteins, Small Molecules, and other ACS product categories. This role is accountable for shaping and executing a portfolio strategy to support Growing and Leveraging the Core. This leader will be instrumental in optimizing portfolio performance through data in alignment with business goals, customer needs, and operational systems. The ideal candidate is strategic and process-oriented, with a collaborative and coaching approach, who will work across team boundaries.
Key Responsibilities:
Strategic Product Life Cycle Management
- Define and execute a structured lifecycle management strategy, incorporating product maturity models and end-of-life strategies to maximize long-term portfolio value.
- Drive analysis and recommendations to inform product evolution and differentiation, including discontinuations vs. next-generation planning based on new applications or market areas.
- Champion the use of data to proactively identify value inflection points such as competitive landscape changes, emerging customer needs, technology shifts, etc.
Portfolio Governance and Optimization
- Design and implement scalable portfolio models, including robust product hierarchies, standardized data structures, and value-based portfolio segmentation aligned to high growth end markets.
- Partner with product management, commercial, and finance leaders to establish dynamic pricing strategies that enable continuous value optimization, not just annual cycles.
- Oversee strategic pricing controls, including discount governance and profitability frameworks to ensure pricing consistency, transparency, and margin integrity across SKUs.
Integrated Business Planning and Operational Alignment
- Represent the portfolio within SIOP, ensuring accurate demand planning inputs, including:
- Customer contractual obligations (e.g., MSAs)
- End-of-life planning and transition timelines
- Multi-lot strategies for demand/supply/quality alignment
- Drive alignment between product plans and operations to support customer commitments and financial targets
NPI Phase-Gate Process
- Co-lead the NPI phase-gate process in close partnership with R&D, Program Management, Marketing, Operations, and Quality teams to ensure a unified, cross-functional approach to new product development and launch.
- Identify and improve time-to-market through streamlined launch processes.
- Continuously improve phase-gate effectiveness by incorporating best practices.
- Serve as a key integrator between end market strategy PM teams and NPI execution.
Qualifications:
- Bachelor’s degree in Business, Life Science, or related field; MBA or equivalent preferred.
- 10+ years of experience in portfolio or product management, preferably in a technology, industrial, or life sciences setting.
- Proven experience with NPI phase-gate processes, lifecycle management, and cross-functional program leadership.
- Strong analytical skills; comfortable working with large data sets and portfolio dashboards.
- Excellent stakeholder management, communication, and decision-making skills.
- Experience with ERP, PLM, or portfolio management tools a plus.
This position is eligible to receive a target annual cash bonus and long-term incentive package of stock grants based on individual and company performance, in accordance with company policy
Why Join Bio-Techne:
- We offer competitive insurance benefits starting on day one: medical, dental, vision, life, short-term disability, long-term disability, pet, and legal and ID shield.
- We invest in our employees’ financial futures through 401k plans, an employee stock purchase plan (ESPP), Health Saving Account (HSA), Flexible Spending Account (FSA), and Dependent Care FSA.
- We empower our employees develop their careers through mentorship, promotional opportunities, training and development, tuition reimbursement, internship programs, and more.
- We offer employee resource groups, volunteer paid time off, employee events, and charity drives to build a culture of caring and belonging.
- We offer an accrued leave policy with paid holidays, paid time off, and paid parental leave.
- We foster a culture of empowerment and innovation, where employees feel valued and encouraged to bring their new ideas to the table.
Bio-Techne is an E-Verify Employer in the United States.
All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.
To protect the interests of all, Bio-Techne will not accept unsolicited resumes from any source other than a candidate application. Any unsolicited resumes sent to Bio-Techne will be considered Bio-Techne property.
Top Skills
What We Do
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers, as well as clinical research laboratories, and constitute the Protein Sciences Segment.
Bio-Techne also develops and manufactures diagnostic products including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for OEM and clinical customers. Bio-Techne’s genomic tools include advanced tissue-based in situ hybridization assays (ISH) for research and clinical use, sold under the ACD brand, as well as a portfolio of clinical molecular diagnostic oncology assays including the ExoDx®Prostate (IntelliScore) test (EPI) for prostate cancer diagnosis. These diagnostic and genomic products comprise Bio-Techne’s Diagnostics and Genomics Segment.
Bio-Techne products are integral components of scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $714 million in net sales in fiscal 2019 and has over 2,200 employees worldwide.
